Stroke. 2014 May;45(5):1589-601. doi: 10.1161/STR.0000000000000014. Epub 2014 Feb 12.
Because stroke is among the leading causes of death, disability, hospitalizations, and healthcare expenditures in the United States, there is interest in reporting outcomes for patients hospitalized with acute ischemic stroke. The American Heart Association/American Stroke Association, as part of its commitment to promote high-quality, evidence-based care for cardiovascular and stroke patients, fully supports the development of properly risk-adjusted outcome measures for stroke. To accurately assess and report hospital-level outcomes, adequate risk adjustment for case mix is essential. During the development of the Centers for Medicare & Medicaid Services 30-day stroke mortality and 30-day stroke readmission measures, concerns were expressed that these measures were not adequately designed because they do not include a valid initial stroke severity measure, such as the National Institutes of Health Stroke Scale. These outcome measures, as currently constructed, may be prone to mischaracterizing the quality of stroke care being delivered by hospitals and may ultimately harm acute ischemic stroke patients. This article details (1) why the Centers for Medicare & Medicaid Services acute ischemic stroke outcome measures in their present form may not provide adequate risk adjustment, (2) why the measures as currently designed may lead to inaccurate representation of hospital performance and have the potential for serious unintended consequences, (3) what activities the American Heart Association/American Stroke Association has engaged in to highlight these concerns to the Centers for Medicare & Medicaid Services and other interested parties, and (4) alternative approaches and opportunities that should be considered for more accurately risk-adjusting 30-day outcomes measures in patients with ischemic stroke.
由于在美国,中风是导致死亡、残疾、住院和医疗支出的主要原因之一,因此人们对报告急性缺血性中风住院患者的结局非常感兴趣。美国心脏协会/美国中风协会作为其致力于为心血管和中风患者提供高质量、基于证据的护理的一部分,全力支持开发适当的风险调整后中风结局衡量指标。为了准确评估和报告医院层面的结果,充分的病例组合风险调整至关重要。在医疗保险和医疗补助服务中心 30 天中风死亡率和 30 天中风再入院率措施的制定过程中,有人表示担心这些措施设计不当,因为它们不包括有效的初始中风严重程度衡量标准,如国立卫生研究院中风量表。这些现有形式的结局衡量标准可能无法充分调整风险,而且可能会错误地描述医院提供的中风护理质量,并最终损害急性缺血性中风患者的利益。本文详细介绍了(1)为什么医疗保险和医疗补助服务中心的急性缺血性中风结局衡量标准在目前的形式下可能无法提供充分的风险调整,(2)为什么目前的设计可能导致不准确地反映医院的表现,并可能产生严重的意外后果,(3)美国心脏协会/美国中风协会为向医疗保险和医疗补助服务中心及其他有关各方强调这些关注所开展的活动,以及(4)应该考虑哪些替代方法和机会,以便更准确地调整缺血性中风患者的 30 天结局衡量标准。